Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050232
Status:
COMPLETED
Last Update Posted:
2016-07-14
First Post:
2002-12-02
Brief Title:
Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals